The obese Zucker rat (OZR) is a model of metabolic syndrome, which has lower skeletal muscle size compared to the lean Zucker rat (LZR). Because satellite cells are essential for postnatal muscle growth, this study was designed to determine if reduced satellite cell proliferation contributes to the reduction of skeletal mass in the OZR compared with the LZR. Satellite cell proliferation was determined by a constant release 5-bromo-2-deoxyuridine (BrdU) pellet that was placed subcutaneously in each animal. Satellite cell proliferation, as determined by incorporation of BrdU, was significantly attenuated in control soleus and plantaris muscles of the OZR compared to the LZR. To determine whether this attenuation of satellite cell activity could be rescued in OZR muscles, the soleus and the gastrocnemius muscles were denervated, placing a compensatory load on the plantaris muscle. There was a ~25% and ~30% increase in the plantaris muscle wet weight compared to the contra-lateral control muscle in the LZR and the OZR, respectively after 21-days of loading. The number of BrdU positive nuclei increased similarly in loaded plantaris muscles from LZR and OZR. Myogenin, MyoD and Akt protein expression, were lower in the control muscles of OZR compared to LZR, but they were all elevated to similar levels in the loaded plantaris muscles of OZR and LZR. These data indicate that metabolic syndrome may reduce satellite cell proliferation and this may be a factor that contributes to the reduced mass in control muscles of OZR; however, satellite cell proliferation can be restored with compensatory loading in OZR.
Introduction
The obese Zucker rat (OZR) is a widely accepted model of metabolic syndrome, which occurs as a result of a homozygous missense mutation of the leptin receptor gene (9) leading to chronic hyperphagia (9, 21) . As a result, the OZR rapidly becomes obese and develops extreme insulin resistance and hypertriglyceridemia, which is accompanied by a clinically relevant hypertension and a prothrombotic and proinflammatory state (5, 16, 20, 22, 28, 36) . Skeletal muscles are considerably smaller in the OZR than in the control lean Zucker rat (LZR) of similar ages. This is important because skeletal muscle, is the primary site of glucose and fat oxidation, both of which are in excess with metabolic syndrome (6, 27) . Therefore, a reduction of skeletal muscle mass would further compromise clinical outcomes in metabolic syndrome.
The lower skeletal muscle mass in the OZR appears to be partly accounted for by an altered balance between protein synthesis and degradation in this model of metabolic syndrome (4, 16) .
However, it has also been observed that there is a decrease in nucleic acid content in the muscles of the OZR compared to the LZR (16) . Replacing nuclei that are lost during normal turnover, and maintaining nuclear content in adult muscle, is a primary responsibility of muscle satellite cells.
Muscle satellite cells are normally quiescent myogenic precursor cells found between the basal lamina and the sarcolemma of a muscle fiber (1) . However, these cells can proliferate in response to a variety of stimuli, and they are responsible for maintenance of the nuclear to cytoplasmic relationship in muscle. Furthermore, postnatal muscle growth and hypertrophy of skeletal muscle, critically depend on the proliferation and differentiation of muscle satellite cells (1, 25) . It is possible that a decrease in satellite cell proliferation could contribute to the decrease in nucleic acid content and skeletal muscle mass observed in the OZR.
Mechanisms that may contribute to lower satellite cell proliferation and differentiation in muscles of the OZR could include decreases in the expression levels of myogenic regulatory factor proteins. Myogenic regulatory factors are muscle-specific helix-loop-helix transcription factors which regulate muscle specific genes (12, 25) . MyoD and myogenin are myogenic regulatory factors which are expressed in activated satellite cells and they are necessary for satellite cell proliferation and differentiation (12, 37) . MyoD and myogenin are reduced during muscle atrophy, and in models of diabetes (3, 13) , although it has not been determined if this corresponds to reduced satellite cell proliferation or differentiation in models of metabolic syndrome. We hypothesized that a decrease in the protein expression of MyoD and myogenin, might result in lower satellite cell proliferation and/or differentiation and lead to lower muscle mass in the OZR model of metabolic syndrome, as compared to the lean phenotype.
Another possible mechanism for disrupted satellite cell proliferation is deregulated protein kinase B/Akt (Akt) signaling. Control of the Akt signaling pathway is essential for muscle growth and hypertrophy (reviewed (7, 19) ). Furthermore, a lower level of activated Akt is associated with attenuated increases in muscle hypertrophy under conditions such as aging (7, 19) . Akt, and specifically Akt2, is essential for proliferation and differentiation of skeletal muscle satellite cells (7, 8) . In the OZR there is a reduced protein expression of Akt2 and reduced activity levels of both Akt1 and Akt2 compared to the LZR (24) . These findings underscore the possibility that Akt signaling may play an important role in the control of satellite cell proliferation and differentiation in muscles of the OZR.
Although the skeletal muscles of the OZR are smaller compared to the LZR, to the best of our knowledge, no study has evaluated whether muscles in the OZR have attenuated hypertrophy in response to loading. While the OZR is significantly less active than the LZR (9), the OZR have much greater body mass, and this should provide a greater stimulus for muscle growth on the weight bearing muscles. Nevertheless, a previous study from our lab in which the daily activity of the OZR was increased through daily treadmill running, demonstrated no increase in the size of the skeletal muscles (18) . These findings suggest that there may be an underlying deficit in the ability of skeletal muscle to respond to increased loading in the OZR model of metabolic syndrome.
The purposes of this study were to determine (i) if there was a decrease in the number of satellite cells in the skeletal muscles of the OZR compared to the LZR (ii) whether satellite cell proliferation is attenuated in OZR compared to the LZR in control muscle; (iii) whether satellite cell proliferation is attenuated in OZR compared to the LZR in loaded muscle; and, (iv) whether the skeletal muscles of the OZR are able to hypertrophy in response to loading. Furthermore, as muscle loading directly activates Akt (31) and MRF signaling (2, 26) , Akt, MyoD, and myogenin protein expression were measured. We hypothesized that Akt and MRF protein expression would be rescued with compensatory hypertrophy in the OZR, and enable a restoration of satellite cell proliferation to levels similar to lean animals.
METHODS
Animal Care. Male LZR (+/fa) and OZR (fa/fa) rats were purchased from Harlan labs (Harlan, Indianapolis, IN). The OZR are homozygous for a recessive missense mutation of the leptin receptor gene which results chronic hyperphagia. The LZR are heterozygous for this mutation but do not shown eating abnormalities (9, 29) . Twelve animals of each phenotype were used in this study. All animals were 12 weeks of age at completion of this study. The animals were housed in pathogen-free conditions, at 20-22°C, and fed rat chow and water ad libitum throughout the study period. The animal care standards were followed by adhering to the recommendations for the care of laboratory animals, as advocated by the American Association for Accreditation of Laboratory Animal Care, which fully conformed to the Animal Welfare Act of the US Department of Health and Human Services. All animal procedures were conducted in accordance with institutional guidelines and ethical approval was obtained from the Animal Care and Use Committee at the West Virginia University prior to carrying out tests.
Compensatory loading protocol. To achieve compensatory hypertrophy of the plantaris muscle, synergist denervation of the soleus and gastrocnemius muscles was used as previously described in our (14) . Briefly, the distal branches of the tibial nerve were transected, therefore, removing the innervation to the soleus muscle and both heads of the gastrocnemius muscle. The severed nerved endings were sutured onto the biceps femoris muscle to prevent reinnervation back to the original muscles (14) . This placed a compensatory load on the plantaris muscle. The contralateral limb received a sham surgery, in which the branches of the tibial nerve were identified but not severed, and this served as an internal control for each animal. All procedures were performed under aseptic conditions. The animals recovered quickly and were alert and walking within ~15 min after surgery. Loading occurred for 7 or 21 days. standards. The mitochondria-free cytosolic protein fraction was isolated as previously described Negative control experiments were done by omitting the BrdU antibody from the tissue sections.
The basal lamina was identified with a primary antibody to anti-laminin (D18; Hybridoma Bank)
followed by a rhodamine conjugated secondary antibody (Santa Cruz Biotechnology, CA). Only the BrdU positive nuclei within the basal lamina were quantified. The BrdU labeling index was calculated as the number of BrdU labeled nuclei . total nuclei -1 . 100. This provided an index of satellite cell proliferation.
Pax7 antibody (PAX7; Developmental Studies, Hybridoma Bank, U. Iowa) was used to determine the number of satellite cells in the control muscles (40) . Since the formalin fixation interfered with the Pax7 antibody, 7µm cross-sections were obtained from frozen mid-belly sections of the muscle as previously performed in our laboratory (34) . Briefly, the sections were air dried at room temperature, fixed in ice-cold methanol-acetone (1:1) for 10 minutes, rinsed in PBS, and permeabilized in 0.2% triton-X in 0.1% sodium citrate. The sections were incubated for 30 minutes in 1.5% goat serum at 37ºC then incubated with a primary antibody to Pax7
followed by Alexa 488. The tissue sections were then probed with anti-Laminin mouse IgG2a (2E8; Hybridoma Bank) followed by a rhodamine conjugated secondary antibody (Santa Cruz Biotechnology, CA).
Immunoblot analysis was completed on 6 non-overlapping tissue cross-sections (40x Table 1 . These data show that the OZR used in our study were obese, hyperinsulinemic, and hyperglycemic. total myonuclei was similar in plantaris and soleus muscles of OZR and LZR animals ( Figure   2A ). However, there were fewer total myonuclei in muscles of OZR animals compared to LZR
animals. There was a significant, ~30% and 20% decrease, in the number of myonuclei per muscle fiber cross section in plantaris and soleus muscles respectively, of OZR compared to the LZR ( Figure 2B ). Together these data signify that although the percentage of satellite cells (as indicated by Pax7) to total myonuclei is not reduced, there are less total myonuclei in the OZR.
This suggests that there was not a preferential loss of satellite cells in the muscles of the OZR, but rather, there was a proportional decrease in the number of satellite cells and myonuclei in muscles of OZR compared to LZR.
Apoptotic signaling proteins. We examined if increased nuclear apoptosis may account
for the fewer nuclei found in muscles fibers of the OZR compared with the LZR. Surprisingly, immunoblot analysis showed similar levels of AIF, ARC, APAF-1, and Bad protein content in control muscles of OZR and LZR (Figure 3) . Similarly, apoptotic nuclei as reflected by the frequency of TUNEL positive nuclei were less than 1% of the total myonuclei and there was no difference in the number of apoptotic nuclei in the muscle cross-sections from LZR and OZR animals. These data suggest that apoptosis is not increased and therefore cannot account for the fewer number of myonuclei and satellite cells in muscles of the OZR compared with the LZR.
Satellite cell proliferation. One possible explanation for the lower number of myonuclei
is that satellite cell proliferation and replacement of nuclei could be impaired in control muscles.
To test this possibility, we examined satellite cell proliferation in the muscles of the OZR compared to the LZR, in control muscles. To determine if satellite cell proliferation could be rescued to contribute to muscle hypertrophy, we examined loaded plantaris muscles. BrdU time release pellets were implanted in all animals to label proliferated satellite cells. In the contralateral control limb there was a significant absence of BrdU positive nuclei in the OZR compared to the LZR in both the plantaris ( Figure 4D ) and soleus muscles ( Figure 4E ). In this study, only one BrdU positive myonuclei was observed in all the control plantaris muscle cross sections that were examined from OZR, and only two BrdU positive myonuclei were observed in all of the control OZR soleus muscles. In contrast, every cross section that was examined in the LZR had a minimum of one BrdU positive nuclei. These data support the hypothesis that there is a decrease in satellite cell proliferation in the control muscles of the OZR compared to the LZR.
On the other hand, loading of the plantaris muscle induced a significant increase in the number of BrdU positive muscle nuclei in both the OZR and LZR ( Figure 4D ). The number of BrdU positive nuclei was similar in loaded muscles from OZR animals. and activity levels are decreased in control muscles of the OZR when compared with the LZR (24) . Because Akt signaling is a major component contributing to skeletal muscle hypertrophy (7, 11) , it was anticipated that the lower Akt protein levels in plantaris muscles of the OZR would result in attenuated hypertrophy in response to compensatory loading compared to the LZR. However, no attenuation of satellite cell proliferation or muscle hypertrophy was found in the OZR after compensatory loading of the plantaris muscle.
Myogenic regulatory factors and
Muscle hypertrophy in response to normal growth or muscle loading in adults is critically dependent on the proliferation and differentiation of satellite cells (30) . Reduction in muscle DNA content (10) as a result of reduced muscle nuclei content (35) is one mechanism contributing to lower muscle transcriptional activity and muscle mass with aging, and potentially leading to sarcopenia in aging. Thus, it is possible that in a similar fashion, reduced proliferation of satellite cells will contribute to lower nuclear content in skeletal muscle of OZR, which may have contributed to reduced muscle mass in control muscles compared with LZR. In this study, satellite cell proliferation was determined by identifying nuclei inside the basal lamina that had incorporated BrdU during compensatory hypertrophy of the plantaris muscle of OZR and LZR.
We would not expect to see a high number of satellite cells being activated in adult skeletal muscle in humans under normal basal conditions. However, unlike humans, rodents, continue to grow throughout their life cycle so one would expect to see a small amount of satellite cell proliferation even in adult rodent muscles. This expectation was confirmed in our finding of BrdU positive myonuclei in the LZR control soleus and plantaris muscles. The initial hypothesis proposed for this study was that satellite cell proliferation would be inhibited in the OZR model of metabolic syndrome, regardless of loading. This hypothesis was partial confirmed by the almost complete absence of BrdU positive myonuclei in the control plantaris and soleus muscles of the OZR. On the other hand, after loading, the number of BrdU positive myonuclei was elevated in the LZR, but surprisingly there was an almost equal amount of BrdU positive nuclei in the loaded plantaris muscle of the OZR and the LZR. We did anticipate that if satellite cell proliferation was restored it would coincide with a restoration of Akt and myogenic regulatory factor protein expression as we observed in this study. Previous studies from our lab and others have shown that loading-induced hypertrophy is accompanied by increases in MyoD and myogenin (2,10), whereas, muscle wasting and aging are usually accompanied by decreases or attenuated increases in protein levels of myogenic transcription factors (2, 15, 26) . In old birds, the lower levels of myogenic regulatory factors appear to result from reduced contributions from satellite cells (25) ; however, restoration of myogenic regulatory factor levels from muscle loading could reflect changes in both myonuclei and satellite cells (25) . In the present study, it is likely that the increased load on the plantaris muscle was sufficient to increase the activation of Akt in a contraction dependent manner (32) and that the increase in Akt induced increased expression of myogenic regulatory factors (23).
Traditional treatments for metabolic syndrome, as recommended by the American Diabetes Association, include weight loss and aerobic exercise. Aerobic exercise increases whole-body glucose disposal and improves insulin sensitivity, mainly through increased expression of GLUT-4 protein (17). However, aerobic exercise is not considered an effective means to induce skeletal muscle hypertrophy. On the other hand, resistance exercise has also been shown to increase glucose transport into the muscle (38) and is widely accepted as a means to induce muscle hypertrophy.
To the best of our knowledge, this is the first study to demonstrate hypertrophy in an animal model of metabolic syndrome. It is important to note that metabolic syndrome did not limit muscle hypertrophic adaptations to increased loading. Another important finding of this study is that there was a restoration of Akt2 protein expression in hypertrophied muscles of OZR after overload. Akt2 specifically has been linked to disruptions in GLUT4 regulation, glucose uptake, as well as skeletal muscle hypertrophy (8, 11, 31) . Skeletal muscle, by virtue of its mass, is the primary site for glucose and fatty acid oxidation, both of which are important complications with metabolic syndrome (6, 27) . These findings suggest that resistance training, or some other form of loading, may be a viable addition to the treatment and/or prevention of metabolic syndrome in humans.
To our knowledge, this is the first study in which satellite cell quantification and proliferation with metabolic syndrome has been investigated. We do not think that increased apoptotic signaling could account for the lower number of myonuclei and satellite cells in crosssections of control muscles of the OZR, because we have failed to observe any increases in markers of apoptosis (TUNEL positive nuclei; protein levels of AIF, Apaf-1, ARC or BAD) in control muscles of the OZR compared with the LZR. Furthermore, it is unlikely that metabolic syndrome attenuates the sustained increases in ribosomes, thereby limiting translational capacity, as is the case in some chronic diseases (1), because in the present study, the plantaris muscles had similar hypertrophic adaptations to compensatory loading in OZR and LZR. We speculate that lower Akt and MyoD levels in control muscles of OZR might in turn result in decreased satellite cell proliferation. This hypothesis is supported by recent data that show that leptin promotes proliferation and inhibits myogenin expression and myoblast differentiation in vitro (39) , and therefore the lack of leptin might result in an inhibition of satellite cell proliferation. In the current study, there was a significant decrease in the protein expression of myogenic regulatory factors, myogenin and MyoD, as well as Akt, which could account for the decreased satellite cell proliferation in the control muscles of the OZR. It is not clear if the lower levels of MyoD and Akt are leptin dependent or independent, or simply a response to or a consequence of metabolic syndrome. Thus, it is possible that deficient leptin signaling or some other aspect of metabolic syndrome attenuates the expression of these proteins. To test this further, other models of obesity and metabolic syndrome would need to be investigated in which leptin levels were manipulated. Nevertheless, in the current study, MyoD, myogenin, and Akt protein expression were restored with loading, indicating that a significant stimulus such as compensatory loading, is capable of overriding the attenuation of these proteins. Our results show that overloadinduced muscle hypertrophy and satellite cell proliferation occurs at similar levels in skeletal muscles of OZR and LZR, suggesting that satellite cell function per se is not limited in metabolic syndrome.
In conclusion, our data suggest that satellite cell proliferation is suppressed in control muscles of OZR with metabolic syndrome. This may lead to an impaired replacement of nuclei during normal turnover, and in turn, may contribute to the reduced number of myonuclei per muscle and the lower muscle mass in animals with metabolic syndrome. These findings underscore the need for further research to more fully understand the mechanisms responsible for attenuated satellite cell proliferation in control muscles in the OZR and to determine if satellite cell activity or proliferation is reduced in other models of metabolic syndrome. 
